Advertisement
U.S. markets closed
  • S&P 500

    5,254.35
    +5.86 (+0.11%)
     
  • Dow 30

    39,807.37
    +47.29 (+0.12%)
     
  • Nasdaq

    16,379.46
    -20.06 (-0.12%)
     
  • Russell 2000

    2,124.55
    +10.20 (+0.48%)
     
  • Crude Oil

    83.11
    +1.76 (+2.16%)
     
  • Gold

    2,254.80
    +42.10 (+1.90%)
     
  • Silver

    25.10
    +0.35 (+1.41%)
     
  • EUR/USD

    1.0792
    -0.0037 (-0.35%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • GBP/USD

    1.2625
    -0.0013 (-0.11%)
     
  • USD/JPY

    151.3580
    +0.1120 (+0.07%)
     
  • Bitcoin USD

    70,812.98
    +1,692.05 (+2.45%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • Nikkei 225

    40,168.07
    -594.66 (-1.46%)
     

Zacks.com featured highlights include Eastside Distilling, Adial Pharmaceuticals, The Buckle, Ruth's Hospitality Group and Insight Enterprises

For Immediate Release

Chicago, IL – August 29, 2022 – Stocks in this week’s article are Eastside Distilling EAST, Adial Pharmaceuticals ADIL, The Buckle BKE, Ruth's Hospitality Group RUTH and Insight Enterprises NSIT.

Forget Bargain Hunting: Play 5 Stocks with Rising P/E

Bargain hunting or looking for stocks with a low price-to-earnings (P/E) ratio is among the widely used investing strategies. Investors believe that the lower the P/E, the higher will be the value of the stock. The logic is simple — a stock's current market price does not justify its higher earnings and therefore leaves room for upside.

But there is more to this whole P/E story as not only low P/E, stocks with a rising P/E can also fetch solid returns.

The screener yields winning stocks like Eastside Distilling, Adial Pharmaceuticals, The Buckle, Ruth's Hospitality Group and Insight Enterprises.

Rising P/E: A Useful Tool

Generally, the price of a stock rallies on a rise in earnings. As forecasts for expected earnings move higher, demand for the stock should drive its price. After all, astock's P/E gives an indication of how much investors are ready to shell out for every dollar of earnings. Thus, if the P/E of a stock is rising steadily, it means that investors are pinning their hopes on the company's inherent strength.

Also, studies have revealed that stocks have seen their P/E ratios jump over 100% from their breakout point in the cycle. So, if you can pick stocks early in their breakout cycle, you can end up seeing considerable gains.

Here are five of the 70 stocks:

Eastside Distilling: The Zacks Rank #2 company is involved in producing handcrafted spirits primarily in the United States. You can see the complete list of today's Zacks #1 Rank stocks here.

The average earnings surprise of EAST for the past four quarters is 25.82%.

Adial Pharmaceuticals: Adial Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. The stock carries a Zacks Rank #2.

The average earnings surprise of ADIL for the past four quarters is 7.84%.

The Buckle: The Zacks Rank #2 company is a leading retailer of medium to better-priced casual apparel, footwear, and accessories for fashion-conscious young men and women.

The average earnings surprise of BKE for the past four quarters is 12.65%.

Ruth's Hospitality Group: The Zacks Rank #2 company is the largest fine dining steakhouse company in the United States as measured by the total number of company-owned and franchisee-owned restaurants.

The average earnings surprise of RUTH for the past four quarters is 35.20%.

Insight Enterprises: The company is a global direct marketer of brand name computers, hardware and software. It has a Zacks Rank #1.

The average earnings surprise of NSIT for the past four quarters is 16.15%.

You can get the rest of the stocks on this list by signing up now for your 2-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and test them first before taking the investment plunge.

The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.

Click here to sign up for a free trial to the Research Wizard today.

For the rest of this Screen of the Week article please visit Zacks.com at: https://www.zacks.com/stock/news/1972791/forget-bargain-hunting-play-5-stocks-with-rising-pe

Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.

About Screen of the Week

Zacks.com created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine.  But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use.

Strong Stocks that Should Be in the News

Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has more than doubled the market from 1988 through 2016. Its average gain has been a stellar +25% per year. See these high-potential stocks free >>.

Follow us on Twitter:  https://www.twitter.com/zacksresearch

Join us on Facebook:  https://www.facebook.com/ZacksInvestmentResearch

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Contact: Jim Giaquinto

Company: Zacks.com

Phone: 312-265-9268

Email: pr@zacks.com

Visit: https://www.zacks.com/

Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Ruth's Hospitality Group, Inc. (RUTH) : Free Stock Analysis Report
 
Buckle, Inc. The (BKE) : Free Stock Analysis Report
 
Insight Enterprises, Inc. (NSIT) : Free Stock Analysis Report
 
Eastside Distilling, Inc. (EAST) : Free Stock Analysis Report
 
Adial Pharmaceuticals, Inc. (ADIL) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

Advertisement